Key facts
| Company | Skytron, LLC |
|---|---|
| FDA office | Center for Devices and Radiological Health |
| Letter date | May 19, 2026 |
| Subject / product | Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k) |
| CFR citations | FDA Warning Letter |
| Response due | 15 working days from receipt (standard FDA warning-letter requirement) |
| Reference / source ID | skytron-llc-723950-05192026 |
What happens next
Skytron, LLC is expected to respond to FDA in writing, typically within 15 working days of the letter date, describing the specific corrective and preventive actions taken or planned for each violation cited. FDA reviews that response and any follow-up evidence, and can conduct a re-inspection to confirm the corrections were actually made. If FDA judges the response inadequate, or the underlying conditions serious enough, further action can follow, including product seizure, injunction, import alert, or civil penalties; many Warning Letters are resolved through corrective action alone. This page reflects the Warning Letter as issued and will not reflect any subsequent correction unless FDA publishes a follow-up record. FDA issues Warning Letters after an inspection or other review when it believes a firm has significantly violated FDA regulations; the letter itself is a notice, not a final adjudication.
Violations explained
FDA Warning Letter — Violations FDA cited at Skytron, LLC
WARNING LETTER Skytron, LLC MARCS-CMS 723950 — May 19, 2026 More Warning Letters Warning Letters About Warning and Close-Out Letters Product: Medical Devices Recipient: Recipient Name David Mehney Recipient Title CEO Skytron, LLC 5085 Corporate Exchange Blvd SE Grand Rapids , MI 49512 United States (b)(6)@Skytron.com Issuing Office: Center for Devices and Radiological Health United States WARNING LETTER May 19, 2026 Dear David Mehney, The United States Food and Drug Administration (FDA or agency) has learned that your firm is marketing the 1140 Sentry, 2280 Syndicate, 3200 Max and UV Smart D25 in the United States without marketing clearance or approval, in violation of the Federal Food, Drug, and Cosmetic Act (the Act). Under section 201(h) of the Act, 21 U.S.C. § 321(h), these products are devices because they are intended for use in the diagnosis of disease or other conditions or in the cure, mitigation, treatment, or prevention of disease, or to affect the structure or any function of the body. FDA has reviewed your firm’s webpages at https://www.skytron.com/infection-prevention-technologies/, https://www.skytron.com/wp-content/uploads/documentation/UVC-Correctional-Disinfection-REV3-WEB.pdf and UV-Smart-D25-Brochure-WEB.pdf and has determined that the 1140 Sentry, 2280 Syndicate, 3200 Max, and UV Smart D25 devices are adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B), because your firm does not have an approved application for premarket approval (PMA) in effect pursuant to section 515(a) of the Act, 21 U.S.C. § 360e(a), or an approved application for an investigational device exemption (IDE) under section 520(g) of the Act, 21 U.S.C. § 360j(g) for the devices as described and marketed. The 1140 Sentry, 2280 Syndicate, 3200 Max, and UV Smart D25 devices are also misbranded under section 502(o) of the Act, 21 U.S.C. § 352(o), because your firm introduced or delivered for introduction into interstate commerce for commercial distribution these devices without submitting a premarket notification to FDA as required by section 510(k) of the Act, 21 U.S.C. § 360(k), and 21 CFR 807.81. The UV Smart D25 device is further misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a) because of your misleading references, identified in the quoted statements below, to your firm’s registration. Your brochure for that device references that product’s FDA registration in the context of “use[] to clean non-invasive medical equipment,” which creates an impression of official FDA approval, clearance, authorization, or endorsement or other evaluation of your products that is misleading and constitutes misbranding. See 21 CFR 807.39. In addition, although there is a 510(k) exemption for medical washer-disinfector devices under 21 CFR 880.6992, which is the regulation (and product code MEC) under which you registered the UV Smart D25 device, the device is not exempt because it is not the type of device that is within the generic category of devices identified under § 880.6992. Generic devices of this type include functional steps that utilize mechanical processes to physically remove contamination from devices followed by a separate disinfection step, which can be either thermal or chemical. However, based on evidence obtained from your website, the UV Smart D25 is described as utilizing UVC to “clean non-invasive medical equipment.” However, we note that the device does not include a mechanical cleaning step, and disinfection is achieved utilizing non-ionizing UV-C radiation, with no mechanical action included. FDA has defined “cleaning” in this context as “the physical removal of soil and contaminants from an item”. 1 In addition, FDA does not consider non-ionizing radiation to fall within the scope of “thermal or chemical” disinfection. As a result, the device fails to qualify for 510(k) exemption under 21 CFR 880.6992 because the device’s technology includes neither a mechanical cleaning nor disinfection step, wh
Skytron, LLC’s FDA history
Argus HQ has recorded 1 total FDA action tied to Skytron, LLC: 1 warning letter, 0 recalls, 0 approval records, and 0 Form 483 inspection citations.
Full letter text
Read the rest of the full text
Frequently asked questions
- What happens after a Warning Letter is issued?
- The firm generally must respond in writing within 15 working days; FDA reviews the response and can escalate to seizure, injunction, or import alert if it judges the response inadequate. Many Warning Letters are resolved through corrective action alone.
- Has Skytron, LLC had other FDA enforcement actions?
- This is the only FDA action Argus HQ has on file for Skytron, LLC so far. Argus ingests new FDA enforcement records daily.
- Which FDA office issued the warning letter to Skytron, LLC?
- Center for Devices and Radiological Health issued the warning letter to Skytron, LLC.
- What CFR citations does this warning letter reference?
- The letter cites: FDA Warning Letter.
Get the next warning letter in this therapeutic area before your team hears about it secondhand.
Weekly briefing, free. Upgrade any time for daily or real-time delivery.
Related enforcement actions
Full FDA history for Skytron, LLC- Warning letter (recent): Med Shop Inc / www.medshopinc.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): ketaminetroches.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketdaxandrugs / www.ketdaxandrugs.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Legit Ketamine Suppliers / www.legitketaminesuppliers.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Store / www.ketaminestore.org — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Buy Keta Online / www.buyketaonline.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): Ketamine Troche Store / www.ketaminetrochestore.com — Unapproved New Drugs/Misbranded (2026-06-23) →
- Warning letter (recent): All Ketamine HCL / www.allketaminehcl.com — Unapproved New Drugs/Misbranded (2026-06-23) →
Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder
Cite this record
Reusing this data in reporting or research? Here’s a ready-made citation.
Argus HQ Research (2026). Skytron, LLC — FDA Warning Letter, May 19, 2026: Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k). Digital Empire LLC. Retrieved from https://argushq.ai/warning-letter/skytron-723950-2026-05-19
"Skytron, LLC — FDA Warning Letter, May 19, 2026: Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/warning-letter/skytron-723950-2026-05-19.
Argus HQ Research. "Skytron, LLC — FDA Warning Letter, May 19, 2026: Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/warning-letter/skytron-723950-2026-05-19.
@misc{argushq_argushq_ai_warning_letter_skytron_723950_2026_05_19_2026,
title = {Skytron, LLC — FDA Warning Letter, May 19, 2026: Medical Device/Adulterated/Misbranded/Lacks PMA and/or 510(k)},
author = {{Argus HQ Research}},
year = {2026},
publisher = {Digital Empire LLC},
url = {https://argushq.ai/warning-letter/skytron-723950-2026-05-19},
note = {Accessed: July 13, 2026}
}Source: FDA.gov — Warning Letters ↗

